BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/3/2026 3:27:48 AM | Browse: 2 | Download: 0
Publication Name World Journal of Virology
Manuscript ID 120124
Country Algeria
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study
Manuscript Source Invited Manuscript
All Author List Khellaf Amalou, Ryma Rekab, Nada Benmellouka, Boutheina Derbal, Ahlem Belloula, Hana Chetroub, Fadel Sabrina, Farid Belghanem and Khadidja Saidani
Funding Agency and Grant Number
Corresponding Author Khellaf Amalou, Assistant Professor, PhD, Department of Gastroenterology, Mohamed Seghir Nekkache, No. 246 Kouba, Algiers 16000, Algeria. amalou_kh@yahoo.fr
Key Words Hepatitis B; Treatment; Discontinuation; Relapse; Re-treatment
Core Tip Prolonged therapy remains the recommended method for patients with chronic hepatitis B. Nonetheless, concerns about treatment adherence and economic strain, particularly in resource-constrained areas, combined with research indicating that virological and clinical remission persists in non-cirrhotic patients after treatment cessation, prompted the development of nucleos(t)ide analog cessation guidelines for specific patients. However, the discontinuation of nucleos(t)ide analog is still a contested question. The median duration until recurrence was 11 months. The cumulative virological relapse rates, defined as chronic hepatitis B deoxyribonucleic acid over 2000 IU/mL, were 25%, 52%, 58%, and 61% at 6 months, 12 months, 24 months, and 36 months, respectively. The cumulative retreatment rates at 6 months, 12 months, 24 months, and 36 months were 19%, 25%, 28%, and 35%, respectively. Histologic fibrosis score > 2 is the unique factor for retreatment.
Citation Amalou K, Rekab R, Benmellouka N, Derbal B, Belloula A, Chetroub H, Sabrina F, Belghanem F, Saidani K. Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study. World J Virol 2026; In press DOI: https://doi.org/10.5501/wjv.120124
Received
2026-03-04 03:33
Peer-Review Started
2026-03-04 03:35
First Decision by Editorial Office Director
2026-04-16 08:15
Return for Revision
2026-04-16 08:15
Revised
2026-06-02 22:31
Publication Fee Transferred
Second Decision by Editor
2026-07-03 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-03 03:27
Articles in Press
2026-07-03 03:27
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3249 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com